A Rubinstein

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Henry N. Ginsberg, Ngoc‐Anh Le, Ira J. Goldberg et al. · Journal of Clinical Investigation · 1986 · 422 citations · Full text

Life Sciences, Biochemistry, Human Nutrition +16

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years

Itamar Grosskopf, T. Rassin, Hylton I. Miller et al. · BMJ · 1996 · 217 citations

Medicine, Cardiology, Nutrition +17

Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects.

J C Gibson, A Rubinstein, Phillip Bukberg et al. · Journal of Lipid Research · 1983 · 107 citations · Full text

Life Sciences, Biochemistry, Biochemical Genetics +14

Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety

Dov Gavish, Eyal Leibovitz, I Shapira et al. · Journal of Internal Medicine · 2000 · 89 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

A Rubinstein, J C Gibson, James R. Paterniti et al. · Journal of Clinical Investigation · 1985 · 83 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +16